3[16]Charles River Laboratories Clinical Services[EB/OL].[2006-01-01].http://www.ribavirinpregnancyregistry.com/announce.htm.
4[1]McBride WG.Thalidomide and congenital abnormalities[J].Lancet,1961,2:1358.
5[2]Schou M; Goldfield MD,Weinstein MR,et al.Lithium and pregnancy.I.Report from the Register of Lithium Babies[J].Br Med J,1973,2:135-136.
6[3]Goldstein DI,Corbin LA,Sundell KL.Effects of first-trimester fluoxetine exposure on the newborn[J].Obstet Gynecol,1997,89:713-718.
7[4]Stone KM,Reiff-Eldridge R,White AD,et al.Pregnancy outcomes following systemic prenatal acyclovir exposure:Conclusions from the international acyclovir pregnancy registry,1984-1999[J].Birth Defects Res A Clin Mol Teratol,2004,70:201-207.
8[5]FDA List of Pregnancy Registries[EB/OL].[2006-01-01].http://www.fda.gov/womens/registries/registries.html.
9[6]Guidance for Industry:Establishing Pregnancy Exposure Registries[EB/OL].[2006-01-01].Http://www.fda.gov/cber/gdlns/pregexp.htm.
10[7]Mitchell AA.Special considerations in studies of drug-induced birth defects[J].In:Strom BL,editor.Pharmacoepidemiology.3rd ed.Chichester:John Wiley & Sons Ltd.2000,749-763.
1.Simultaneous multiresponse optimization of an HPLC method to separate seven cephalosporins in plasma and amniotic fluid: Application to validation and quantification of cefepime, cefixime and cefoperazone[J].Talanta.2009(1)
